D-dimer is not a long-term prognostic marker following acute cerebral ischemia

被引:31
作者
Squizzato, Alessandro
Ageno, Walter
Finazzi, Sergio
Mera, Valentina
Romualdi, Erica
Bossi, Anna
Venco, Achille
机构
[1] Univ Insubria, Dept Clin Med, Varese, Italy
[2] Osped Legano, Dept Clin Chem, Legnano, Italy
[3] Univ Milan, Dept Med Stat, Milan, Italy
关键词
D-dimer; stroke; prognosis;
D O I
10.1097/01.mbc.0000224850.57872.d0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent evidence indicates a possible role of D-dimer in the early diagnosis of ischemic stroke subtypes. Whether D-dimer can also predict the long-term outcome following ischemic stroke is controversial. To define the prognostic role of D-dimer, patients hospitalized after an acute ischemic cerebrovascular event underwent D-dimer measurement (Liatest D-D; normal level < 0.50 mu g/ml) on admission and were followed up for recurrent cerebrovascular events, occurrence of other cardiovascular events, and mortality. We enrolled 96 patients (mean age 74.9 years, 42 men). Mean follow-up was 61.5 months; 47 (48.5%) patients died, 23 (48.9%) because of a vascular event. There was no difference in mean D-dimer levels between dead patients and survivors (1.68 and 1.63 mu g/ml, P = NS), but the mortality risk was higher with D-dimer of at least 0.50 mu g/ml (odds ratio, 5.32; 95% confidence interval, 1.79-15.84). After adjustment for age and stroke subtype, the odds ratio was not significant. Mean D-dimer was similar between patients with and without a new vascular event (1.43 and 1.68 mu g/ml, P = NS), and D-dimer of at least 0.50 mu g/ml was not predictive of an increased risk of subsequent events. D-dimer levels measured in the acute phase after an acute cerebrovascular event probably do not predict the long-term clinical outcome.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 21 条
  • [1] Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes
    Ageno, W
    Finazzi, S
    Steidl, L
    Biotti, MG
    Mera, V
    d'Eril, GM
    Venco, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (22) : 2589 - 2593
  • [2] [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI DOI 10.1016/0895-4356(88)90084-4
  • [3] [Anonymous], 2002, World Health Report, 2002: Reducing risks, promoting healthy life
  • [4] CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION
    BAMFORD, J
    SANDERCOCK, P
    DENNIS, M
    BURN, J
    WARLOW, C
    [J]. LANCET, 1991, 337 (8756) : 1521 - 1526
  • [5] LONG-TERM RISK OF RECURRENT STROKE AFTER A FIRST-EVER STROKE - THE OXFORDSHIRE COMMUNITY STROKE PROJECT
    BURN, J
    DENNIS, M
    BAMFORD, J
    SANDERCOCK, P
    WADE, D
    WARLOW, C
    [J]. STROKE, 1994, 25 (02) : 333 - 337
  • [6] Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients
    Di Napoli, M
    Papa, F
    [J]. STROKE, 2002, 33 (07) : 1763 - 1771
  • [7] Hemostatic markers in acute ischemic stroke - Association with stroke type, severity, and outcome
    Feinberg, WM
    Erickson, LP
    Bruck, D
    Kittelson, J
    [J]. STROKE, 1996, 27 (08) : 1296 - 1300
  • [8] Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations
    Hankey, GJ
    Warlow, CI
    [J]. LANCET, 1999, 354 (9188) : 1457 - 1463
  • [9] Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    Hart, RG
    Benavente, O
    McBride, R
    Pearce, LA
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) : 492 - +
  • [10] INTERRATER RELIABILITY OF AN ETIOLOGIC CLASSIFICATION OF ISCHEMIC STROKE
    JOHNSON, CJ
    KITTNER, SJ
    MCCARTER, RJ
    SLOAN, MA
    STERN, BJ
    BUCHHOLZ, D
    PRICE, TR
    [J]. STROKE, 1995, 26 (01) : 46 - 51